Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-03

Clinical Trial Update: Pulmonary Hypertension: Intensification and Personalisation of Combination Rx [Phase 4]

View source ↗

Summary

Phase 4 clinical trial recruiting to evaluate intensification and personalisation of combination therapy for Pulmonary Arterial Hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust | Conditions: Pulmonary Arterial Hypertension | Phase 4 | Status: RECRUITING